top of page
Epygenix Therapeutics has been acquired by Harmony Biosciences, a pharmaceutical company dedicated to developing and commercializing
innovative therapies for patients with rare neurological diseases. For more information on Harmony and the acquisition, please click here
The Argus Trial is continuing uninterrupted with Harmony Biosciences.
Contact
General Inquiries
To learn more about Harmony Biosciences, please complete the form below and we will be in touch.
Harmony Biosciences
630 W. Germantown Pike
Suite 215
Plymouth Meeting, PA 19462
​
Phone: +1 484-539-9800
bottom of page